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Developing a risk proﬁle for spontaneous preterm
birth and short interval to delivery among patients
with threatened preterm labor
Ashten B. Waks, MD, MSPH; L. Carolina Martinez-King, MD, MS; Gisselle Santiago, BS;
Louise C. Laurent, MD, PhD; Marni B. Jacobs, PhD, MPH

BACKGROUND: Threatened preterm birth is the most common reason for antepartum hospitalization in the United States, accounting for
approximately 50% of these admissions. However, fewer than 10% of
patients with inpatient evaluation for signs or symptoms of preterm labor
ultimately deliver before term.
OBJECTIVE: This study aimed to generate predictive models to assess
the risk of preterm delivery and time to delivery based on clinical signs
and symptoms of patients evaluated in our institution for preterm labor
concerns.
STUDY DESIGN: This was a retrospective cohort study of singleton
pregnancies evaluated for signs and/or symptoms of preterm labor,
including contractions, abdominal pain, vaginal bleeding, and short cervix,
between 22 0/7 and 33 6/7 weeks of gestation. Inpatient evaluations
were classiﬁed by patient presentation: (1) symptomatic with cervical ﬁndings (transvaginal cervical length of <2.5 cm or cervical dilation of ≥2.0
cm), (2) asymptomatic with cervical ﬁndings, and (3) symptomatic without
cervical ﬁndings. The primary outcomes included incidence of spontaneous preterm birth and interval from presentation to delivery, compared
between groups. The risk of preterm delivery was evaluated using logbinomial regression, and presentation to delivery timing was assessed by
survival analysis and Cox proportional hazards modeling.
RESULTS: Of 631 patients with preterm labor concerns, 96 (16%) were
symptomatic with cervical ﬁndings on evaluation, 51 (8%) were asymptomatic with cervical ﬁndings, and 466 (76%) were symptomatic without
cervical ﬁndings. The occurrence of preterm birth was signiﬁcantly higher
among symptomatic patients with cervical ﬁndings (49%) than among
those with cervical ﬁndings alone (31%) or symptoms alone (11%)
(P<.0001). In addition, symptomatic patients with cervical ﬁndings were
signiﬁcantly more likely to deliver within 48 hours (20%), 1 week (30%), 2

P

reterm birth is deﬁned as delivery
between 20 and 37 weeks of gestation and represents >10% of all liveborn deliveries in the United States.1−4
Currently, preterm delivery is the
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weeks (33%), and 1 month (43%) of presentation than patients with cervical ﬁndings alone (2%, 2%, 6%, and 10%, respectively) or symptoms
alone (0.4%, 1%, 1.5%, and 5%, respectively) (P value for trend<.0001).
Adjusted for gestational age at presentation and previous preterm birth,
the overall risk of preterm delivery was signiﬁcantly higher among patients
with symptoms and cervical ﬁndings than among patients with cervical
ﬁndings alone (relative risk, 2.81; 95% conﬁdence interval, 1.74−4.54)
or symptoms alone (relative risk, 4.39; 95% conﬁdence interval, 3.16
−6.09). Adjusted for the same variables, symptomatic patients with cervical ﬁndings were also at higher risk of delivery over time after assessment
than patients with cervical ﬁndings alone (hazard ratio, 2.06; 95% conﬁdence interval, 1.47−2.90) or symptoms alone (hazard ratio, 2.16; 95%
conﬁdence interval, 1.74−2.70). The negative predictive value of these
models suggested that only 1% of patients with isolated symptoms or cervical ﬁndings are at risk of preterm delivery within 1 week of initial
presentation.
CONCLUSION: Symptomatic patients with cervical ﬁndings suggestive
of preterm labor were at the greatest risk of preterm birth and a shorter
interval from presentation to delivery. The study ﬁndings supported a risk
proﬁle that may facilitate the selection of patients most appropriate for
admission and targeted management. Nonetheless, as nearly 50% of
patients meeting this risk proﬁle subsequently deliver at term, future
research is needed to identify which of these patients will require
intervention.
Key words: abdominal pain in pregnancy, antepartum hospital admis-

sion, delivery timing, incidence of preterm delivery, labor and delivery triage, premature cervical dilation, preterm contractions, preterm vaginal
bleeding, short cervix

leading cause of neonatal mortality in
this country, with up to 66% of infant
deaths observed in neonates born before
37 weeks of gestation.5 Those that survive often require prolonged hospitalizations for complications of prematurity,
such as respiratory distress, neurodevelopmental sequelae, and feeding difﬁculties.6 Beyond its association with
neonatal outcomes, threatened preterm
birth is also the most commonly cited
reason for antepartum hospitalization,
encompassing 44% to 59% of all antenatal admissions and contributing to medical expenses exceeding $26 billion
annually.2,7,8

Spontaneous preterm birth accounts
for up to 70% of all preterm deliveries.1−3
The recognition of risk factors for spontaneous preterm delivery—including previous preterm birth, previous cervical
surgery, infection, short interpregnancy
interval, maternal age, substance use,
African American race, and low socioeconomic status1,2,9−11—has improved
our ability to identify vulnerable patients.
Furthermore, the identiﬁcation of these
patients has been enhanced by routine
incorporation of strategies, such as serial
vaginal examinations, transvaginal cervical length, and fetal ﬁbronectin in the
evaluation of preterm labor symptoms.
November 2022 AJOG MFM
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Why was this study conducted?
Threatened preterm birth accounts for 50% of antepartum hospitalizations in
the United States; however, only 10% of these admissions result in preterm
delivery. This study aimed to identify a risk proﬁle for those patients who ultimately deliver before term.
Key ﬁndings
Patients with both symptoms (eg, uterine contractions) and cervical ﬁndings
consistent with preterm labor are at high risk of preterm delivery. In the absence
of both concerns, our models predicted that fewer than 1% of patients will
deliver within 1 week of presentation.
What does this add to what is known?
Existing studies have examined associations between isolated symptoms and
cervical ﬁndings concerning preterm labor. Our study expanded on the literature
by generating predictive models to compare the risk of preterm delivery among
those with isolated symptoms, isolated cervical ﬁndings, or a combination of the
2 concerns.
Nonetheless, although risk factors for or
clinical ﬁndings consistent with preterm
labor are present in up to 50% of patients
who deliver before term, fewer than 10%
of patients with an identiﬁed risk factor
for or clinical ﬁnding consistent with preterm labor deliver before 37 weeks of
gestation.11,12
Accordingly, we designed a study to
predict the risk of preterm birth and the
interval to delivery among patients presenting with preterm labor concerns.
We hypothesized that patients with preterm labor symptoms and associated
cervical ﬁndings would be at the greatest risk of preterm delivery and in closer
proximity to initial presentation than
patients with isolated symptoms or cervical ﬁndings.

Materials and Methods
Study population
We conducted a retrospective cohort
study at the University of California,
San Diego (UCSD), a tertiary referral
center serving a metropolitan area. The
study was approved by the UCSD Institutional Review Board. Electronic medical records (EMRs) were reviewed for
all patients delivered at UCSD from July
1, 2015, to June 30, 2017, who had at
least 1 documented labor and delivery
triage or antepartum unit encounter
between 22 0/7 and 33 6/7 weeks of gestation. The latter of these dates was
2 AJOG MFM November 2022

established as the sampling endpoint
because, after this time, our institution
implemented new protocols for managing preterm labor between 34 0/7 and
36 6/7 weeks of gestation. In addition,
records were screened, and patients
whose encounters involved a chief complaint of contractions, vaginal bleeding,
abdominal pain, or short cervix identiﬁed on outpatient ultrasound1,9,10 were
included in the study cohort. Patients
diagnosed with morbidly adherent placentation or preterm premature rupture
of
membranes
(PPROM)
were
excluded, as management of labor
symptoms in these patients is different
from the management of the same
symptoms in the general obstetrical
population.13,14
For patients with multiple eligible
encounters within a pregnancy, only the
ﬁrst encounter was selected for the present analysis because of the concern that
early ﬁndings and management had the
potential to affect clinical decision-making in subsequent encounters. For
patients with >1 delivery in the study
period, the ﬁrst eligible encounter in
each pregnancy was included. Only
20% of study patients had >1 eligible
encounter, and only 5% of study
patients had >2 eligible encounters.
Although included in preliminary
screening, patients with multiple pregnancies were later excluded from this

analysis given their 6-fold greater risk of
preterm delivery compared with singleton pregnancies.15

Data collection
For each eligible encounter, data regarding patients’ symptoms, cervical ﬁndings, and disposition status were
extracted from the EMR. Cervical ﬁndings noted were cervical dilation by sterile vaginal examination and cervical
length by transvaginal ultrasound,
although included patients were
required to have only 1 of these ﬁndings
documented, as use of both assessments
varied by provider. In addition, the following socioeconomic, obstetrical, and
medical characteristics were abstracted:
age at delivery, race and ethnicity, insurance coverage, parity, history of preterm
delivery or cervical surgery, body mass
index, and diagnosis of comorbid
conditions (eg, hypertension or diabetes
mellitus). Given the body of literature
implicating these characteristics as
risk factors for preterm birth,1,2,9−11
they were considered potentially relevant confounders in multivariable
regression models.
Using the abstracted data, patients
were classiﬁed into 3 groups based on
their symptoms and cervical ﬁndings on
presentation. Across all groups, symptomatic was deﬁned as a patient complaint of contractions, vaginal bleeding,
or abdominal pain. Cervical ﬁndings
were deﬁned as a transvaginal cervical
length of <2.5 cm or a cervical dilation
of ≥2 cm on digital examination.9,16
The ﬁrst group consisted of symptomatic patients with cervical ﬁndings suggestive of preterm labor; the second
group consisted of asymptomatic
patients with incidental cervical ﬁndings suggestive of preterm labor; and
the third group consisted of symptomatic patients without cervical ﬁndings
suggestive of preterm labor. Of note, 33
patients had a chief complaint unrelated
to preterm labor but were assessed
because of ﬁndings of contractions on
tocometry. As they could not be classiﬁed into 1 of 3 presentation groups,
they were excluded from the analysis.
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Outcomes
Of note, 2 primary outcomes were considered: (1) incidence of preterm birth
before 34 0/7 weeks of gestation and (2)
time from the initial encounter to delivery. The secondary outcomes included
gestational age at the time of delivery
and neonatal birthweight.

Statistical analysis
Analyses were completed using SAS
(version 9.4; SAS Institute, Cary, NC),
and a 2-sided P value of .05 was considered signiﬁcant for all analyses. Demographic and clinical characteristics were
compared across presentation groups
using analysis of variance for continuous variables and chi-squared or Fisher
exact test for categorical variables. Subsequently, the occurrence of preterm
birth and delivery timing from the initial encounter were assessed. The relative risk (RR) of preterm delivery
among groups was evaluated using logbinomial regression, alone and adjusted
for relevant risk factors that differed signiﬁcantly between groups at P<.05 in
bivariate analyses.

Based on ﬁndings from logistic
regression models, receiver operating
characteristic (ROC) curves were constructed for preterm delivery and
delivery within 1 week of presentation.
The area under the ROC curve (AUC)
was calculated to evaluate the diagnostic utility of the models generated. An
AUC of >0.7 was taken to represent
an accurate model. Predictive statistics
were also calculated, including positive predictive value, negative predictive value (NPV), sensitivity, and
speciﬁcity.
Time from the initial encounter to
delivery between groups was examined
using Kaplan-Meier survival curves,
and associated hazard ratios (HRs) for
delivery were estimated using Cox proportional hazards models. A review of
the survival curves suggested that
asymptomatic patients with cervical
ﬁndings and symptomatic patients
without cervical ﬁndings overlapped
approximately 80 days from the initial
encounter, potentially violating the proportional hazards assumption. As such,
hazards models were run for all time

points and for time points limited to
80 days from the initial encounter.

Results
Figure 1 outlines the selection of the
study population. Of 2699 identiﬁed
encounters, 944 (35%) involved a chief
complaint worrisome for preterm labor
between 22 0/7 and 33 6/7 weeks of gestation. Following the exclusion criteria,
84 encounters (9%) for preterm labor
concerns were excluded for the diagnoses of PPROM or morbidly adherent
placentation. Of eligible encounters, 160
(19%) were excluded because of the
identiﬁcation of an earlier encounter
with the same patient. Of eligible ﬁrst
encounters, 87 (12%) were excluded
because of multiple pregnancies or the
inability to classify the patient into 1 of
3 presentation groups. This resulted in
a cohort of 613 patients for analysis.
Of included patients, 96 (16%) were
symptomatic with cervical ﬁndings at
the time of initial evaluation, 51 (8%)
were asymptomatic with incidental cervical ﬁndings, and 466 (76%) were
symptomatic without cervical ﬁndings.

FIGURE 1

Flow diagram for derivation of the study population

a

Electronic medical record (EMR); bPreterm premature rupture of membranes (PPROM); cEncounters for multiple pregnancies (n=54) and patients who
could not be classiﬁed into 1 of 3 presentation groups (n=33).
Waks. Risk proﬁle for spontaneous preterm birth. Am J Obstet Gynecol MFM 2022.
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The characteristics of the study population are presented in Table 1. Patients
with both symptoms and cervical ﬁndings and symptoms alone were evaluated at later gestational ages (P=.004),
whereas patients with cervical ﬁndings
alone were more likely to have a history
of preterm birth (P<.0001). Slight differences in maternal age (P=.06) and
insurance status (P=.05) were noted,
although no signiﬁcant difference in
parity, race and ethnicity, history of

cervical surgery, or obstetrical comorbidities were seen.
Patient symptoms and examination
ﬁndings at the time of the initial
encounter are presented in Table 2.
Contractions were the most reported
symptom among those with both symptoms and cervical ﬁndings (51%),
whereas vaginal bleeding was the most
reported symptom among those with
symptoms alone (47%). Across presentation groups, 85% of all patients

underwent transvaginal cervical length
assessment, 32% had a digital examination to assess cervical dilation, and >9%
had fetal ﬁbronectin collected. Based on
these examinations, shortened cervix
was identiﬁed in 75% of patients with
both symptoms and cervical ﬁndings
and 100% of patients with cervical ﬁndings alone; premature cervical dilation
was identiﬁed in 47% of patients with
both symptoms and cervical ﬁndings
and 14% of patients with cervical

TABLE 1

Baseline characteristics of the study population by presentation group
n (%)

Characteristic

Symptomatic with
cervical ﬁndings
(n=96)

Asymptomatic with
cervical ﬁndings
(n=51)

Symptomatic
without ﬁndings
(n=466)

Age, mean (SD)

29.6 (6.1)

31.3 (6.3)

31.1 (5.9)

.06

28.9 (3.6)

27.1 (3.4)

28.7 (3.4)

.004

a

Gestational age, mean (SD)
Parity

P value

.69

Nulliparous

42 (43.7)

21 (41.2)

204 (43.8)

1−2

46 (47.9)

25 (49.0)

207 (44.2)

3−4

6 (6.3)

3 (5.9)

47 (10.1)

≥5

2 (2.1)

2 (3.9)

8 (1.7)

White

32 (33.3)

11 (21.6)

164 (35.2)

Hispanic

37 (38.5)

25 (49.0)

173 (37.1)

8 (8.3)

3 (5.9)

29 (6.2)

Race or ethnic status

Black
Asian
Other, unknown

.60

7 (7.3)

7 (13.7)

45 (9.7)

12 (12.5)

5 (9.8)

55 (11.8)

Insurance status

.05

Private

37 (39.4)

15 (29.4)

216 (47.1)

Government funded

55 (58.5)

32 (62.7)

225 (49.0)

2 (2.1)

4 (7.8)

18 (3.9)

Previous preterm delivery

25 (26.0)

20 (39.2)

61 (13.1)

<.0001

Previous cervical surgery

10 (10.4)

4 (7.8)

24 (5.2)

.13

28.9 (10.4)

28.4 (6.9)

28.2 (7.9)

.76

Uninsured, other

BMI, mean (SD)
Obstetrical comorbidities
Hypertensive conditions
Diabetes mellitus

b

14 (14.7)

10 (19.6)

87 (19.0)

.60

17 (17.7)

16 (31.4)

88 (18.9)

.09

Data are presented as number (percentage), unless otherwise indicated.
BMI, body mass index; SD, standard deviation.
Gestational age at ﬁrst encounter.

a

b

Preexisting or gestational.

Waks. Risk proﬁle for spontaneous preterm birth. Am J Obstet Gynecol MFM 2022.
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TABLE 2

Symptoms, examination strategy, and ﬁndings by presentation group
n (%)
Symptomatic with cervical
ﬁndings (n=96)

Variable

Asymptomatic with cervical
ﬁndings (n=51)

Symptomatic without
ﬁndings (n=466)

Total (N=613)

Symptoms
Contractions

51 (51.3)

0 (0.0)

132 (28.3)

183 (29.8)

Vaginal bleeding

27 (28.1)

0 (0.0)

263 (56.4)

290 (47.3)

Abdominal pain

22 (22.9)

0 (0.0)

102 (21.9)

124 (20.2)

Cervical length

74 (77.1)

43 (84.3)

403 (86.5)

520 (84.8)

Cervical dilation

65 (67.7)

22 (43.1)

110 (23.6)

197 (32.1)

Fetal ﬁbronectin

27 (28.1)

3 (5.9)

23 (5.0)

53 (8.6)

72 (75.0)

51 (100.0)

0 (0.0)

123 (20.0)

Examination strategy

Examination ﬁndings
Short cervixa
b

0.2−4.9

0.1−4.6

2.5−6.0

0.1−6.0

Premature cervical dilationc

45 (46.9)

7 (13.7)

0 (0.0)

52 (8.5)

Cervical dilation, IQRb

0−10

0−9

0−1

0−10

Positive fetal ﬁbronectin

13 (48.2)

0 (0.0)

0 (0.0)

13 (2.1)

Cervical length, IQR

Data are presented as number (percentage), unless otherwise indicated.
IQR, interquartile range.
Deﬁned as a cervical length of <2.5 cm

a

b

Minimum and maximum values in centimeters

Deﬁned as a cervical dilation of ≥2 cm on digital examination.

c

Waks. Risk proﬁle for spontaneous preterm birth. Am J Obstet Gynecol MFM 2022.

ﬁndings alone; and a positive fetal ﬁbronectin was identiﬁed in nearly 50% of
patients with both symptoms and cervical ﬁndings but not in patients with isolated cervical ﬁndings or symptoms.
Table 3 depicts the primary outcomes. Patients with both symptoms
and cervical ﬁndings were signiﬁcantly
more likely to deliver before term than
those with isolated cervical ﬁndings or
symptoms (P<.0001). Considering the
interval from presentation to delivery,
symptomatic patients with cervical ﬁndings were also more likely to deliver
within 48 hours, 1 week, 2 weeks, and 1
month than those with isolated cervical
ﬁndings or symptoms (P<.0001).
Patients with both symptoms and cervical ﬁndings also had an earlier mean
gestational age at delivery and a lower
mean neonatal birthweight relative to
patients with isolated cervical ﬁndings
or symptoms (P<.0001).

The trend toward a greater incidence
of preterm delivery and a shorter time to
delivery among patients with both symptoms and cervical ﬁndings vs those with
cervical ﬁndings or symptoms alone is
further supported by the regression models presented in Table 4. Speciﬁcally, the
risk of preterm delivery was nearly 3 to
4 times greater among patients with
symptoms and cervical ﬁndings than
among asymptomatic patients with cervical ﬁndings (RR, 2.8; 95% conﬁdence
interval [CI], 1.7−4.5) or symptomatic
patients without cervical ﬁndings (RR,
4.4; 95% CI, 3.2−6.1). The risk of preterm
delivery within 1 week of presentation—
an interval crucial for optimal timing of
antenatal corticosteroid administration—
was 35 times greater among patients with
both symptoms and cervical ﬁndings
than patients with symptoms alone (RR,
35.2; 95% CI, 12.7−97.8). Adjusted for
gestational age at presentation and history

of preterm birth, both of which were signiﬁcant in bivariate analyses, the risk of
preterm delivery overall and within 1
week of presentation between patients
with symptoms and cervical ﬁndings
(adjusted RR [aRR], 4.1; 95% CI, 3.0
−5.8) and patients with isolated symptoms (aRR, 35.3; 95% CI, 12.7−98.2) and
between patients with isolated cervical
ﬁndings (aRR, 2.4; 95% CI, 1.5−3.9) and
patients with isolated symptoms (aRR,
2.2; 95% CI, 0.3−19.7) remained consistent. Additional adjustment for known
risk factors for preterm delivery, including
maternal age and socioeconomic status,
did not materially alter these estimates
and thus were not included.
Given the larger proportion of
patients with both symptoms and cervical ﬁndings who delivered prematurely,
this group was considered “positive”
screening cases in the predictive modeling included in Table 4. The NPV for
November 2022 AJOG MFM
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TABLE 3

Delivery outcomes by presentation group
n (%)
Symptomatic with
cervical ﬁndings (n=96)

Outcome
Preterm delivery

Asymptomatic with
cervical ﬁndings (n=51)

Symptomatic without
ﬁndings (n=466)

P value

47 (49.0)

16 (31.4)

52 (11.2)

<.0001

40.5 (34.0)

67.7 (30.7)

71.3 (26.8)

<.0001

Presentation to delivery
Days, mean (SD)
Within 48 h

19 (19.8)

1 (2.0)

2 (0.4)

<.0001

Within 1 wk

29 (30.2)

1 (2.0)

4 (0.9)

<.0001

Within 2 wk

32 (33.3)

3 (5.9)

7 (1.5)

<.0001

Within 30 d

41 (42.7)

5 (9.8)

24 (5.2)

<.0001

34.6 (5.5)

36.7 (4.2)

38.8 (2.0)

<.0001

2502.4 (1100.5)

2740.2 (879.8)

3264.7 (601.7)

<.0001

Gestational age at delivery, mean (SD)
Birthweight (g), mean (SD)

Data are presented as number (percentage), unless otherwise indicated.
SD, standard deviation.
Waks. Risk proﬁle for spontaneous preterm birth. Am J Obstet Gynecol MFM 2022.

the overall preterm birth model suggested that only 13% of patients with
isolated symptoms or cervical ﬁndings
of preterm labor will ultimately experience a preterm delivery. The NPV for
the model focused on preterm delivery

within 1 week of presentation suggested
that only 1% of patients with isolated
symptoms or cervical ﬁndings of preterm labor will experience a delivery
within 1 week of their initial encounter.
Additional ROC curves were generated

to identify which speciﬁc cervical ﬁndings were most predictive of preterm
delivery and demonstrated that a cervical length of ≤2.17 cm (sensitivity of
0.86 and speciﬁcity of 0.90) and cervical
dilation of ≥2.0 cm (sensitivity of 0.71

TABLE 4

Risk of delivery by presentation group
Crude model

Predictive ﬁndings

Adjusted modela

RR

95% CI

RR

95% CI

AUCb Sensitivity (%)c Speciﬁcity (%)d

PPV (%)e

NPV (%)f

Symptomatic with cervical ﬁndings

4.4

3.2−6.1

4.1

3.0−5.8

0.66 40.9

90.2

49.0

86.9

Asymptomatic with cervical ﬁndings

2.8

1.7−4.5

2.4

1.5−3.9

—

Ref

—

Symptomatic with cervical ﬁndings

35.2 12.6−97.8 35.3 12.7−98.2 0.87 85.3

88.4

30.2

99.0

Asymptomatic with cervical ﬁndings

2.3

Presentation category
Preterm birth

Symptomatic without cervical ﬁndings Ref
Preterm birth within 1 wk of presentation

Symptomatic without cervical ﬁndings Ref

0.3−20.1

2.2

03−19.7

—

Ref

—

AUC, area under the receiver operating characteristic curve; CI, conﬁdence interval; NPV, negative predictive value; PPV, positive predictive value; Ref, reference interval; RR, relative risk.
a

RR ratios were adjusted for gestational age at presentation and before preterm birth
AUC for the crude model among symptomatic patients with cervical ﬁndings

b

Sensitivity of the crude model among symptomatic patients with cervical ﬁndings

c

Speciﬁcity of the crude model among symptomatic patients with cervical ﬁndings

d

PPV of the crude model among symptomatic patients with cervical ﬁndings

e

NPV of the crude model among symptomatic patients with cervical ﬁndings.

f

Waks. Risk proﬁle for spontaneous preterm birth. Am J Obstet Gynecol MFM 2022.
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FIGURE 2

Kaplan-Meier survival curves for time to delivery by presentation category

patients evaluated for preterm labor concerns between 22 0/7 and 33 6/7 weeks of
gestation. As hypothesized, patients with
a combination of symptoms and cervical
ﬁndings threatening preterm labor were
at the greatest risk of preterm delivery
and within a shorter time from the initial
encounter. Nearly 50% of these patients
experienced preterm birth, and more
than 30% of these patients delivered
within 1 week of presentation.

Results and clinical implications

At any time within the study period, patients with both symptoms and cervical ﬁndings consistent
with preterm labor are at signiﬁcantly increased risk of delivery relative to those with symptoms or
cervical ﬁndings in isolation (P<.0001).
Waks. Risk proﬁle for spontaneous preterm birth. Am J Obstet Gynecol MFM 2022.

and speciﬁcity of 0.87) at the initial
encounter conferred the greatest risk.
To better understand the continuum of
preterm labor for the highest-risk patients,
latency was also evaluated among those
with both symptoms and cervical ﬁndings
who had not yet delivered within 48 hours
of initial presentation. Only 17 (22%) of
these patients had additional encounters
for preterm labor concerns, with a mean
latency period of 44.7 days between representation and delivery for those with 1
additional encounter and 47.2 days for
those with 2 additional encounters.
Regarding preterm labor symptoms at representation, contractions were associated
with a mean latency period of 45.6 days,
vaginal bleeding with a mean latency
period of 56.5 days, and abdominal pain
with a mean latency period of 39.2 days.
Regarding cervical ﬁndings on re-presentation, sonographic short cervix was associated with a mean latency period of
50.8 days, whereas premature cervical
dilation was associated with a shorter
mean latency period of 39.0 days.
To further explore the time to delivery across presentation groups, KaplanMeier survival curves are presented in

Figure 2. The survival time for patients
with both symptoms and cervical ﬁndings was signiﬁcantly shorter than that
for patients with either isolated symptoms or cervical ﬁndings (P<.0001).
Speciﬁcally, at any given time from their
initial encounter, symptomatic patients
with cervical ﬁndings were more than
2 times more likely to deliver than those
with cervical ﬁndings (HR, 2.06; 95%
CI, 1.47−2.90) or symptoms alone (HR,
2.16; 95% CI, 1.74−2.70). Associations
were slightly attenuated, but remained
signiﬁcant, following the adjustment for
gestational age at presentation and history of preterm birth (symptoms and
cervical ﬁndings vs cervical ﬁndings
alone: adjusted HR [aHR], 1.43 [95%
CI, 1.01−2.01]; symptoms and cervical
ﬁndings vs symptoms alone: aHR, 1.91
[95% CI, 1.53−2.39]). The results were
similar when limiting deliveries within
80 days and censoring deliveries beyond
80 days after the encounter.

Discussion
Principal ﬁndings
We analyzed the incidence of preterm
birth and the interval to delivery in 613

Earlier studies interrogating the natural history of preterm labor focused
on the association between premature
cervical dilation or short cervix and
interval to delivery. Both How et al17
and Tommaso et al18 evaluated
patients presenting with preterm contractions between 22 0/7 and 34 0/7
weeks of gestation and identiﬁed an
inverse relationship between cervical
dilation and delivery interval. Speciﬁcally, they found that 6% to 48% of
patients with 0 to 2 cm of cervical
dilation delivered within 48 hours
compared with at least 85% of patients
with cervical dilation of ≥3 cm.17,18
Although our results supported a similar trend between cervical dilation
and delivery timing, a cervical dilation
of 2.0 cm was sufﬁcient to confer an
increased risk of preterm delivery
among our patient population.
Hiersch et al19 and Tsoi et al20
expanded on this research by assessing
the predictive value of transvaginal cervical length in women with preterm
contractions. Their ﬁndings suggested
that a cervical length <2.5 cm is associated with a signiﬁcantly increased risk
of preterm delivery and delivery within
14 days of presentation.19,20 Our results
indicated a comparable relationship
between a short cervix and the likelihood of preterm delivery, although we
found that a shorter cervical length of
2.17 cm was more predictive of delivery
timing.

Strengths and limitations
The differences in our ﬁndings relative
to those cited in the literature may be
attributed to 2 study strengths. First, we
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captured a larger and more diverse population than was included in the previously conducted analyses. Second,
although the previously published studies focused exclusively on contractions
as a symptom of threatened preterm
labor, we expanded our deﬁnition to
include other commonly observed
symptoms of preterm labor, such as
abdominal pain and vaginal bleeding.
A potential limitation of this study
was the inclusion of 51 patients (7.9%)
transferred to our institution for higher
level of care. As only patients who
delivered at our institution were eligible for study selection, lower-risk
patients who were transferred but ultimately discharged to deliver with an
outside provider were excluded.
Accordingly, our sample may overrepresent those patients with preterm
labor concerns who ultimately delivered before term. Another limitation
may involve our approach to multiple
patient encounters within a pregnancy.
The decision to include only the ﬁrst
encounter may have caused us to overlook later encounters with clinical ﬁndings more predictive of a patient’s later
delivery outcome. However, we felt
that examination of the ﬁrst encounter
provided the most relevant assessment
for directing decision-making in these
patients.
Further limitations arose from differences in the examination techniques and tools used among providers
(attending physicians, midwives, and
trainees) at our institution. This manifested as limited uniformity in our
evaluation of preterm labor, such that
up to 15% and 68% of patients had no
documented cervical length or cervical dilation, respectively. Similarly, we
observed substantial variability in the
use of fetal ﬁbronectin across providers, with <9% of study patients
undergoing fetal ﬁbronectin assessment. Therefore, we decided to
exclude fetal ﬁbronectin results from
our predictive modeling and were
unable to compare our ﬁndings with
those of prominent studies by Boots
et al21 and DeFranco et al,22 which
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have found that the combination of
cervical length and fetal ﬁbronectin is
a strong short-term predictor of preterm delivery.

Conclusions and research
implications
Regardless of the study limitations, we
hope that establishing a risk proﬁle for
preterm birth based on the patient’s
initial presentation will facilitate targeted future management of threatened
preterm labor. Our results suggested
that the risk proﬁle should include
chief complaints of uterine contractions; vaginal bleeding; or abdominal
pain paired with cervical dilation of
>2.0 cm, shortened cervix of <2.2 cm,
or both. Despite strong evidence to
support these conclusions, it must be
stated that nearly 50% of our patients
meeting the highest risk proﬁle for
spontaneous preterm birth subsequently delivered at term. Therefore,
further research is needed to identify
which patients with this proﬁle will
beneﬁt the most from the intervention.
&
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